SWOT Analysis for Chemed Corp.

Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over the Quarter (3 Months)
Annual Profit Growth higher than Sector Profit Growth
Relative Outperformance versus Industry over 10 Years
High Momentum Scores (Technical Scores greater than 50)
Company with Low Debt
Increasing Revenue every Quarter for the past 4 Quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Increasing profits every quarter for the past 3 quarters
RSI indicating price strength
Stocks near 52 Week High with Significant Volumes
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter

PE higher than Industry PE
PEG greater than Industry PEG
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of shareholder funds - ROE declining in the last 2 years
Top Losers
Declining Net Cash Flow : Companies not able to generate net cash
Top Losers

Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts
Mutual Funds Increased Shareholding in Past Month
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mf buying for 2 months